Fibrema

Human Fibrinogen (Fibrema) is a plasma-derived protein used to manage bleeding disorders. It plays a crucial role in blood clotting and is often administered intravenously.

Human Fibrinogen, also known as Fibrema, is primarily used to treat bleeding disorders where fibrinogen levels are low. It is often utilized in situations where rapid clotting is necessary, such as during surgery or in cases of severe trauma. The primary use of Fibrema is to support the body's natural clotting process, helping to prevent excessive blood loss.

When administered intravenously, Human Fibrinogen works to enhance the blood's ability to clot. This can help reduce bleeding and support wound healing. Common effects may include improved clotting at the site of injury or surgery, contributing to overall hemostasis.

Human Fibrinogen should be handled with care, ensuring proper storage and administration protocols are followed. It is essential to use this product under the guidance of a healthcare professional to minimize potential risks. Always check for any signs of contamination or adverse reactions before and during use.

Human Fibrinogen may interact with other medications that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions. Additionally, caution should be exercised when using Fibrema in conjunction with other blood products.